Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-10,962
Closed -$356K 281
2017
Q1
$356K Buy
10,962
+9,803
+846% +$309K 0.11% 109
2016
Q4
$36K Sell
1,159
-1,054
-48% -$32.2K 0.01% 134
2016
Q3
$71K Sell
2,213
-11,805
-84% -$395K 0.01% 180
2016
Q2
$468K Buy
14,018
+13,604
+3,286% +$434K 0.02% 428
2016
Q1
$1.17M Buy
414
+145
+54% +$4.14K 0.05% 170
2015
Q4
$823K Sell
269
-428
-61% -$13.5K 0.03% 310
2015
Q3
$2.08M Sell
697
-26,391
-97% -$846K 0.02% 105
2015
Q2
$862K Buy
27,088
+10,646
+65% +$347K 0.02% 332
2015
Q1
$543K Sell
16,442
-23,083
-58% -$734K 0.02% 391
2014
Q4
$1.17M Sell
39,525
-422
-1% -$12.1K 0.03% 286
2014
Q3
$1.12M Buy
39,947
+31,620
+380% +$887K 0.04% 235
2014
Q2
$234K Sell
8,327
-31,725
-79% -$904K 0.01% 489
2014
Q1
$1.22M Sell
40,052
-21,080
-34% -$629K 0.06% 176
2013
Q4
$1.78M Buy
61,132
+24,242
+66% +$706K 0.17% 138
2013
Q3
$1M Buy
36,890
+17,918
+94% +$488K 0.16% 179
2013
Q2
$504K Buy
+18,972
New +$524K 0.2% 132

Other funds holding PFE

Jump Trading's PFE Position: Q2 2020 in Review

Jump Trading opened a new position in Pfizer (PFE) in Q2 2020: 29,890 shares worth $927K. The stake represents 0.62% of the portfolio and ranks #23 among its holdings. This is a return to the name: Jump Trading previously reported a position in PFE as recently as Q4 2017.

Jump Trading first reported a position in PFE in Q4 2013 and has held it in 10 quarters since. The position peaked at $964K in Q1 2016. 2,442 funds tracked by Wall St. Rank hold PFE as of Q2 2020.

  • Jump Trading held 29,890 shares of Pfizer worth $927K as of Q2 2020.
  • Pfizer was a new Jump Trading position in Q2 2020.
  • Pfizer made up 0.62% of Jump Trading's portfolio in Q2 2020, its #23 holding.
  • Jump Trading first reported a position in Pfizer in Q4 2013 and has held it in 10 quarters since.
  • Jump Trading's Pfizer position peaked at $964K in Q1 2016.
  • 2,442 funds tracked by Wall St. Rank held Pfizer as of Q2 2020.

Based on Jump Trading's 13F filing for Q2 2020, filed 3 Aug 2020.